Corporate Governance

 

 

Leadership Team

• Pierre Cassigneul, President and Chief Executive Officer
• James Yee, M.D., Ph.D., Chief Medical Officer
• Jean Viret, Ph.D., Chief Financial Officer
• Tod Klingler, Ph.D., Vice President Information Sciences
• Dirk Lammerts, M.D., Vice President Marketing and Corporate Development
• Mitchell J. Nelles, Ph.D., Vice President R&D/Technical Operations
• Rebecca Soler, Vice President Human Resources

 

Board of Directors

• Brook Byers (Chairman), Kleiner Perkins Caufield & Byers
• Pierre Cassigneul, XDx, Inc.
• Dr. Fred Cohen, TPG Ventures
• Vijay Lathi, New Leaf Venture Partners
• G. Steven Burrill, Burrill & Company
• David Levison, CardioDX
• Dr. Ralph Snyderman, Duke University
• Dr. Peter Altman, BioCardia

 

Code of Business Conduct and Ethics

 

XDx is committed to sound principles of corporate governance. To this end, XDx has developed a set of ethics and compliance policies and procedures to guide our sales and marketing activities. These policies are based on the AdvaMed Code of Conduct, which represents industry standards for the medical device industry. XDx is committed to building on its history of corporate integrity to maintain the highest standards of honesty and professionalism.

• Documents

  • XDx Compliance Policy. To download document click here.

• Compliance Committee Members

  • Rebecca Soler, Chief Compliance Officer and Vice President, Human Resources
  • Rose Romeo, Executive Director, Regulatory Affairs and Quality Assurance